Yabao Pharmaceutical Group Company Limited operates in the Medicinals and botanicals sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Yabao Pharmaceutical Group Company Limited with three other
companies in this sector in China:
Xiamen Kingdomway Group Co
sales of 1.66 billion Chinese Renmimbi [US$246.48 million]
of which 99%
Zhejiang Jingxin Pharmaceutical Co., Ltd.
(1.87 billion Chinese Renmimbi [US$277.92 million]
of which 57%
was Pharmaceutical Ingredient), and
Zhejiang Jiuzhou Pharmaceutical Co Ltd
(1.65 billion Chinese Renmimbi [US$245.03 million]
Yabao Pharmaceutical Group Company Limited reported sales of 1.81 billion Chinese Renmimbi (US$267.72 million)
December of 2016.
decrease of 12.5%
versus 2015, when the company's sales were 2.07 billion Chinese Renmimbi.
The sales level in 2016 was fairly close to the level five years ago: in 2011, Yabao Pharmaceutical Group Company Limited had sales
of 1.66 billion Chinese Renmimbi.
Contributing to the drop in overall sales was the 19.6% decline
in Pharrmaceutical Manufacturing, from 1.65 billion Chinese Renmimbi to 1.32 billion Chinese Renmimbi.
There were also decreases in sales in
Other Operations (down 9.2% to 11.46 million Chinese Renmimbi)
However, these declines were partially offset by the increase in sales of
Pharmaceutical Wholesale (up 16.3% to 459.61 million Chinese Renmimbi)
Other (up 1.7% to 10.66 million Chinese Renmimbi)